Professor, First hospital of Jilin University, China
Niu Junqi is a distinguished professor and chief of the Department of Infectious Diseases at the First Hospital of Jilin University, China. With extensive experience in hepatology, his research focuses on Hepatitis B, Hepatitis C, liver fibrosis, and hepatocellular carcinoma. He has contributed significantly to the epidemiology and therapeutic clinical trials of chronic liver diseases. Over the years, he has held esteemed positions, including Vice President of the First Hospital at Jilin University. His work has earned him numerous national and provincial recognitions. With a prolific academic record, he has authored over 180 publications and accumulated thousands of citations. He continues to lead pioneering research in liver disease treatments, making substantial contributions to the medical field.
PROFESSIONAL PROFILE
Scopus
EDUCATION 🎓
- M.D. (1978-1982): Jilin Medical College, Jilin, China
- M.S. (1985-1988): Norman Bethune University of Medical Sciences, Changchun, China
- Ph.D. (1996-2000): Norman Bethune University of Medical Sciences, Changchun, China
EXPERIENCE 💼
- 1988-1992: Assistant Professor & Physician, Norman Bethune University of Medical Sciences
- 1992-1994: Visiting Fellow, Dept. of Medicine, St. Mary’s Hospital, Imperial College London, UK
- 1994-1997: Associate Professor & Consultant Physician, Dept. of Infectious Diseases, Norman Bethune University of Medical Sciences
- 1997-1999: Senior Visiting Fellow, University of Connecticut Health Center, USA
- 1999-Present: Professor & Chief, Dept. of Infectious Diseases, First Hospital, Jilin University
- 2001-2012: Vice President, First Hospital, Jilin University
AWARDS AND HONORS 🏆
- 2005: Top Creative Talent Award, Jilin Province
- 2008: Young Experts with Outstanding Contributions, China Ministry of Health
- 2009: Top Ten Famous Doctors of Jilin University
- 2010: Special Award of State Government
- 2011: Senior Expert Award, Jilin Province
RESEARCH FOCUS 🔬
Niu Junqi’s research revolves around Hepatitis B, Hepatitis C, hepatocellular carcinoma, liver fibrosis, and cirrhosis. His work includes epidemiological studies, treatment innovations, and clinical trials targeting chronic liver diseases, particularly non-alcoholic fatty liver disease. His research significantly contributes to improving diagnostic accuracy, disease management, and therapeutic strategies in hepatology.
PUBLICATION TOP NOTES 📑
- Activation of immune checkpoint OX40 inhibits HBV replication in a mouse model
- Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk
- Safety, Pharmacokinetics, and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine
- Diammonium Glycyrrhizinate Ameliorates Alcohol-Induced Liver Injury
- Safety, Pharmacokinetics, and Antiviral Efficacy of GST-HG141 in Chronic Hepatitis B Patients
- ELISA Genotyping of Hepatitis B Virus in China with Antibodies for Genotypes B and C
- Exosomes Target HBV-Host Interactions to Remodel the Hepatic Immune Microenvironment
- TIR8 Protects Against Nonalcoholic Steatohepatitis by Reducing Lipotoxicity and Inflammation
- High-Accuracy Model for HBsAg Loss in Long-Term Antiviral Therapy
- System Analysis Identifies SOX7 as a Regulator of Hepatic Stellate Cell Activation
CONCLUSION
Niu Junqi is a leading expert in hepatology, with vast contributions to Hepatitis B & C research, liver disease treatment, and clinical trials. His pioneering work in liver fibrosis and hepatocellular carcinoma continues to shape the field, advancing both diagnosis and therapeutic strategies. With numerous awards, extensive experience, and impactful research, he remains a key figure in infectious disease and hepatology studies.